Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

Clinical trial NCT04856124 · COMPLETED

Trial details

NCT number: NCT04856124
Sponsor: Psych Atlanta
Status: COMPLETED
Study type: OBSERVATIONAL

Treatment Resistant Depression

Start date: 2018-09-01
Primary completion: 2020-12-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.